Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149958 (
complex partial seizures
)
2,563
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated in dogs the effect of graded frequencies of electrical vagal stimulation (1.5, 3, 6, and 12
cps
) on pancreatic exocrine secretion and on portal blood levels of
gastrin
, secretin, cholecystokinin (CCK), vasoactive intestinal peptide (VIP), and somatostatin (STS). Stimuli of all four frequencies, each with a duration of 5 minutes, were applied with a secretin background of 0.25 CU/kg-hr, and one stimulatory period of 12
cps
was applied without a secretin background. With secretin, a significant, frequency-dependent increase of volume and of pancreatic protein secretion occurred from 3 to 12
cps
.
Gastrin
values increased significantly at all frequencies. VIP and STS increased significantly with 3, 6, and 12
cps
. Maximal responses for
gastrin
, VIP, and STS were observed with 6
cps
. Peak values for
gastrin
and VIP were found during stimulation, whereas STS peaked after the end of the stimulatory period. The integrated responses of
gastrin
and STS showed significant correlation (P less than 0.01). The results suggest that vagally induced pancreatic response is only partially mediated by
gastrin
and perhaps VIP, and that endogenous
gastrin
may be one of the releasing factors for somatostatin. Plasma levels of CCK and secretin did not change after electrical stimulation, which provides direct evidence that their release is unlikely to be under vagal control, and that CCK does not mediate the protein secretion obtained after electrical stimulation of the vagus.
...
PMID:Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide, and somatostatin. 46 78